glp-1 parkinson's disease glp 1 drugs for A Big Week GLP-1 Drugs and Parkinson's Disease:

What tier is it on

A realistic low-effort week is usually better than waiting until you are drained and then eating whatever is closest

Support in Reducing Certain Cravings: Some evidence indicates that these medications might play a role in modulating the brain's reward pathways, potentially helping to reduce cravings for certain foods and possibly even impacting addictive behaviours, such as those related to alcohol consumption

doi:10.1016/j.envres.2018.10.007

A comprehensive 2026 review examining peptide and peptide-analogue use across sport and bodybuilding contexts (PMID 41880199) identified ipamorelin as one of the most widely circulating GHRPs in non-clinical settings, noting that its pharmacological profile including reduced risk of ACTH-mediated adverse effects relative to older GHRPs has contributed to its prominence in both research and off-label demographics

clinical protocols typically use 250-500 mcg per injection near the site of injury Cycle length: 6-12 weeks, followed by a 4-8 week break before repeating Research status: Evidence is almost entirely from rodent and small animal models, where BPC-157 has consistently improved functional, structural, and biomechanical outcomes across muscle, tendon, ligament, and bone injuries